2017’s top advancements in gut microbiome science

28 Dec 2017

by GMFH Editing Team

The Gut Microbiota for Health (GMFH) digital community was more active in 2017 than in any previous year—with over 50,000 scientists, healthcare professionals, and members of the public now taking part in the online conversation about gut microbiota! The website

A recent randomised placebo-controlled trial, led by Prof. Thomas Borody from the Centre for Digestive Diseases in Sydney (Australia), has found that faecal microbiota transplantation induces clinical remission and endoscopic improvement in patients with active ulcerative colitis.

A recent study, led by Prof. Brian K. Coombes from the Department of Biochemistry and Biomedical Sciences at the McMaster University in Hamilton, Ontario (Canada), has found that AIEC colonization along with acute infectious gastroenteritis worsened clinical outcome and increased mortality in mice, and also that the infectious diarrhoea caused by microbes promoted growth of AIEC and heightened the inflammatory state in the gut.

Go to Top